Dr. Marc Matrana, MD
Claim this profileOchsner Medical Center Jefferson
About Marc Matrana, MD
Education:
- Earned an MD from Louisiana State University School of Medicine, New Orleans, in 2007.
- Completed Residency in Internal Medicine at Ochsner Clinic Foundation in 2010.
- Completed Fellowship in Hematology/Oncology at Ochsner Clinic Foundation in 2013.
Experience:
- Assistant Professor of Medicine at the University of Queensland School of Medicine – Ochsner Clinical School.
- Director of the Alvin J. Blumkin Center for Innovation and Research in Lung Cancer at Ochsner Health.
- Specializes in lung cancer and thoracic oncology.
Area of expertise
Lung Cancer
Marc Matrana, MD has run 13 trials for Lung Cancer. Some of their research focus areas include:
Cancer
Marc Matrana, MD has run 8 trials for Cancer. Some of their research focus areas include:
Affiliated Hospitals
Ochsner Medical Center Jefferson
Ochsner High Grove
Clinical Trials Marc Matrana, MD is currently running
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Immunotherapy + Targeted Therapy
for Genitourinary Cancers
This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving cabozantinib, nivolumab, or ipilimumab alone.
Recruiting
1 award
Phase 2
21 criteria
More about Marc Matrana, MD
Clinical Trial Related
6 years of experience running clinical trials · Led 26 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Marc Matrana, MD has experience with
- Pembrolizumab
- Nivolumab
- Ipilimumab
- Gemcitabine
- Gemcitabine Hydrochloride
- Docetaxel
Breakdown of trials Marc Matrana, MD has run
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Colon Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Marc Matrana, MD specialize in?
Marc Matrana, MD focuses on Lung Cancer and Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is Marc Matrana, MD currently recruiting for clinical trials?
Yes, Marc Matrana, MD is currently recruiting for 4 clinical trials in New Orleans Louisiana. If you're interested in participating, you should apply.
Are there any treatments that Marc Matrana, MD has studied deeply?
Yes, Marc Matrana, MD has studied treatments such as Pembrolizumab, Nivolumab, Ipilimumab.
What is the best way to schedule an appointment with Marc Matrana, MD?
Apply for one of the trials that Marc Matrana, MD is conducting.
What is the office address of Marc Matrana, MD?
The office of Marc Matrana, MD is located at: Ochsner Medical Center Jefferson, New Orleans, Louisiana 70121 United States. This is the address for their practice at the Ochsner Medical Center Jefferson.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.